World Business NewsA round up of the latest news for those doing business internationally
FDA orders GlaxoSmithKline to review manufacturing worldwide
Zone(s): USA, UK ¦ Sector(s): Manufacturing
It is another serious blow to Britain’s biggest drugmaker, already reeling from corruption allegations in Poland, Iraq, Jordan, Lebanon and China, and facing a criminal investigation by the UK’s Serious Fraud Office into its sales practices. It also recently paid out £63m to settle US marketing allegations. Earlier this week GSK had to apologise for the pitch adopted by a marketing firm working for the FTSE 100 company to recruit unpaid interns for clinical trials in the UK.